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Abstract
Background: Beijing genotype strains are the most predominant strains in China. The aim of this study was to
explore risk factors and clinical phenotypes associated with infection with Beijing genotype strains among
tuberculosis patients in China.
Methods: Using data and strains derived from the first Chinese national drug resistance base-line survey, we
performed a statistical analysis of the relationship between different genotypes, demographic characteristics and
clinical phenotypes.
Result: Of patients infected with the 3634 strains for which detailed information was available, we found that
people in young age groups [aged under 25 years, OR (95% CI): 1.30(1.03-1.62)], urban people [OR (95% CI): 1.18
(0.47-0.94)], or of Hui ethnicity [OR (95% CI): 1.96 (1.10-3.50)] or those needing retreatment [OR (95% CI): 1.22
(1.03-1.43)] were more likely to be infected with Beijing genotype strains compared with patients who were rural, or
of Han ethnicity or those with new TB cases. In contrast, Uyghur [OR (95% CI): 0.45 (0.30-0.67)], or Zhuang
ethnicities [OR (95% CI): 0.30 (0.19-0.48)], presented lower than average risk in infections with the Beijing genotype
strain. In addition, a higher proportion of patients with hemoptysis [OR (95% CI): 0.81 (0.69-0.94)] and chest pain
[OR (95% CI): 0.79 (0.69-0.91)] were infected with non-Beijing genotype strains than with Beijing genotype strains.
Conclusions: In China, young age group, urban people, Hui ethnicity and the earlier treated patients are all high
risk factors for infection with Beijing genotype strains, while Uyghur and Zhuang ethnicity are lower than average
risk factors for infection. The high rate of chest symptoms occurring in non-Beijing genotype infected patients
indicates that more attention should be paid to basic research on non-Beijing genotype strains.
Background
Despite global efforts to combat tuberculosis (TB), TB
is the most widespread infectious disease in the world
[1]. According to a World Health Organization (WHO)
report, TB causes nearly 50 to 100 million infections,
9.4 million new cases and 1.3 million deaths every year
[2,3], and the situation in developing countries is espe-
cially serious. China has the second-highest TB-burden
globally, behind only India [3], and data from the 5th
national TB epidemiological survey conducted in 2010
indicate that TB has an estimated incidence of 459 cases
per 100,000 [95% confidence interval (CI): 433–484]
in China, with 4.99 million prevalent TB cases (95% CI:
4.71-5.27), including 1.19 million pulmonary, bacterio-
logically confirmed cases (95% CI: 1.03-1.35) [4]. Although
both incidence and mortality rate decreased from 2000 to
2010, TB is still a major public health problem in China
due to lack of health-care facilities and other social
constraints.
Among the various M. tuberculosis genotypes, the
Beijing genotype is one of the most prevalent spoligo-
types worldwide, especially in eastern Asia, South Africa,
and northern Eurasia [5-9], and has been responsible for
outbreaks of multidrug-resistant tuberculosis in several
parts of the world [10-12]. As shown in many albeit not
all settings, various characteristics of the Beijing geno-
type, including its higher virulence, ability to escape
from BCG vaccine–induced protection, and significant
association with multidrug resistance, may be respon-
sible for its rapid dissemination [7,13-17]. To date, few
studies have focused on the risk factors and clinical phe-
notypes associated with M. tuberculosis Beijing genotype
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strains in patients with tuberculosis. Young age (0–25 years
of age) and HIV co-infection are reported to be risk fac-
tors for Beijing genotype infection in different settings
[18,19]. Parwati et al. have shown that, in Indonesia, TB
treatment is less effective against Beijing genotype strains
even when drug resistance is not involved [20]. Hence,
an investigation of the risk factors and clinical pheno-
types associated with the Beijing genotype in regions
where the Beijing genotype is the endemically prevalent
strain may have important implications for Tuberculosis
Control Programs. In another study [21], we spoligotyped
the strains isolated from the first national drug resistance
base-line survey of China [22]; 62.2% of these strains
were identified as having the Beijing genotype. Here, we
explore the risk factors and clinical phenotypes of Beijing
genotype strains among tuberculosis patients in China,
using spoligotyping data and patient information derived
from the above study.
Methods
Patient information and bacterial strains
The protocols applied in this study were approved by
the Ethics Committee of the Chinese Center for Disease
Control and Prevention. All patients enrolled in the sur-
veillance provided written informed consent, and per-
sonal information, including demographic chrematistics
and clinical phenotypes.
A total of 4017 clinical strains of tuberculosis, isolated
from the base-line surveillance of tuberculosis in 2007
[22], were collected from 31 provinces covered by the
National TB Control Program (NTP) in China. The
number of patients enrolled in surveillance was propor-
tionally based on patient numbers in different provinces.
Cultures from different survey points were transferred
to the National Tuberculosis Reference Laboratory by
air. Bacterial strains were then recovered on L-J medium
for 4 weeks at 37°C. Genomic DNA was extracted from
fresh cultures as reported previously [23]. In brief, spoli-
gotyping was performed with an available spoligotyping
kit (Isogen Bioscience BV) according to the manufac-
turer’s protocol [21]. Beijing genotype strains were
defined as those which hybridized with all of the last
nine spacer oligonucleotides (spacers 35 to 43) and none
of the first 34 spacer oligonucleotides, while Beijing-like
genotype strains were those that hybridized to only some
of the last nine spacers.
Data analysis
Differences in demographic and clinical characteristics
between patients infected with M. tuberculosis Beijing
genotype strains and patients infected with non-Beijing
genotype strains were analyzed by the chi-square test
and expressed as odds ratios (ORs) with 95% confidence
intervals (CIs). The multivariate analysis was conducted
using the surveylogistic process. All calculations were
performed in SPSS 11.5 (SPSS Inc., USA), and the level
of significance of univariate analysis was 0.05, and that
of multivariate analysis was 0.10. The corrected R2 was
used as the standard for model screening.
Results
M. tuberculosis strains were isolated from 3634 patients
who had positive sputum smear results and detailed
demographic and clinical information. Spoligotyping
analysis indicated that 2290 (63%) of these strains
belonged to the Beijing genotype. A classification of
patients infected with a Beijing genotype strain, stratified
according to gender, age, ethnicity, occupation, educa-
tion and income, is shown in Table 1. Overall, the per-
centage of men infected with a Beijing genotype strain
was similar to that of women, and education level, in-
come, family size and average family income had no in-
fluence on the prevalence of infection with Beijing
genotype strains in China. We found that the prevalence
of infection with Beijing genotype strains was higher
among young patients [aged under 25 years OR (95%
CI): 1.30(1.03-1.62)].
Statistical analysis revealed that the percentage of
people infected with Beijing genotype strains differed
according to ethnicity. Compared with the percentage of
Beijing genotype strains isolated from people of Han
ethnicity, the percentage of strains isolated from people
of Hui ethnicity [OR (95% CI): 1.96 (1.10-3.50)] was
higher, while the percentage of strains isolated from
people of Uyghur [OR (95% CI): 0.45 (0.30-0.67)],
Zhuang [OR (95% CI): 0.30 (0.19-0.48)] and other
Chinese ethnicities [OR (95% CI): 0.67(0.48-0.93)] was
significantly lower. There were no statistically significant
differences in the rate of infection with Beijing genotype
strains between Han and Tibetan ethnicities.
Occupations associated with infection with Beijing or
non-Beijing strains were compared. As shown in Table 1,
there were significantly more urban people [OR (95%
CI): 1.18 (0.47-0.94)] among tuberculosis patients
infected with Beijing genotype strains, indicating that
urban people are a risk factor for infection with strains
of the Beijing genotype. We also performed the multi-
variate analysis towards the distribution of people
infected with Beijing genotype strains based on the uni-
variate analysis. As shown in Table 2, the analysis data
revealed that young age group, urban people and Hui
ethnicity are all high risk factors for infection with
Beijing genotype strains, while Uyghur and Zhuang eth-
nicity are lower than average risk factors for infection,
similar to univariate analysis.
Clinical phenotypes of patients infected with Beijing
genotype or non-Beijing genotype strains are shown in
Table 3. The percentage of cases requiring retreatment
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Table 1 Demographic characteristics of tuberculosis patients according to Mycobacterium tuberculosis genotype
Characteristic Beijing genotype Non-Beijing genotypes Odds ratios P
value(2290) (1344) (95% CI)
N (%) N (%)
Sex
Male 1637(71.5%) 964(71.7%) 1.00 -
Female 653(28.5%) 380(28.3%) 1.01(0.87-1.18) 0.909
Age group (years)
<25 403(17.6%) 202(15.0%) 1.30(1.03-1.62) 0.025
25-34 353(15.4%) 210(15.6%) 1.09(0.87-1.37) 0.452
35-44 391(17.1%) 233(17.3%) 1.09(0.87-1.36) 0.464
45-54 393(17.2%) 208(15.5%) 1.23(0.98-1.54) 0.076
55-64 316(13.8%) 209(15.6%) 0.98(0.78-1.24) 0.906
>65 434(18.9%) 282(21.0%) 1.00 -
Ethnicity
Han 2073(90.5%) 1151(85.6%) 1.00 -
Hui 53(2.3%) 15(1.1%) 1.96(1.10-3.50) 0.021
Tibetan 12(0.5%) 5(0.4%) 1.33(0.47-3.79) 0.800
Uyghur 46(2.0%) 57(4.2%) 0.45(0.30-0.67) <0.001
Zhuang 27(1.2%) 50(3.7%) 0.30(0.19-0.48) <0.001
Others 79(3.4%) 66(4.9%) 0.67(0.48-0.93) 0.017
Occupation
Rural 1470(64.2%) 912(67.9%) 1.00 -
Urban 820(35.8%) 432(32.1%) 1.18(1.02-1.36) 0.025
Education Level
Illiterate 465(20.3%) 274(20.4%) 1.00 -
Primary school 686(30.0%) 448(33.3%) 0.90(0.75-1.09) 0.308
Middle school 719(31.4%) 432(32.1%) 0.98(0.81-1.19) 0.846
High school 319(13.9%) 148(11.0%) 1.27(0.99-1.62) 0.063
University 101(4.4%) 41(3.1%) 1.45(0.98-2.15) 0.069
Income (USD)
<348 446(19.5%) 244(18.2%) 1.00 -
348-583 516(22.5%) 293(21.8%) 0.96(0.78-1.19) 0.746
584-2778 1112(48.6%) 685(51.0%) 0.89(0.74-1.07) 0.211
2779-6944 181(7.9%) 109(8.1%) 0.91(0.68-1.21) 0.513
>6944 35(1.5%) 13(1.0%) 1.47(0.77-2.84) 0.275
Number of family members (Person)
1-2 555(24.2%) 300(22.3%) 1.00 -
3-5 1401(61.2%) 850(63.2%) 0.89(0.76-1.05) 0.170
>5 334(14.6%) 194(14.4%) 0.93(0.74-1.17) 0.564
Average family income (USD)
<116 495(21.6%) 272(20.2%) 1.00 -
116-336 758(33.1%) 436(32.4%) 0.96(0.79-1.16) 0.665
337-560 321(14.0%) 185(13.8%) 0.95(0.76-1.20) 0.720
>560 716(31.3%) 451(33.6%) 0.87(0.72-1.05) 0.164
CI, confidence interval.
Rural, the people who live in rural communities.
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[OR (95% CI): 1.22 (1.03-1.43)] was higher among
people infected with Beijing genotype strains than
among people infected with non-Beijing genotype
strains. We also examined relationship between infection
with Beijing genotype strains and clinical symptoms. A
cough was the most common symptom for both Beijing
and non-Beijing genotype strain infected patients, and
there was no significant difference in the incidence of
this symptom between these two groups. A significantly
lower percentage of Beijing genotype infected patients
with hemoptysis [OR (95% CI): 0.81 (0.69-0.94)] and
chest pain [OR (95% CI): 0.79 (0.69-0.91)] was observed,
using patients infected with non-Beijing genotype strains
as a reference. In contrast, fever [OR (95% CI): 1.25
(1.09-1.43)] was more frequently observed in patients
infected with Beijing genotype strains than in those
infected with non-Beijing genotype strains. In addition,
TB contact history and the use of DOTS monitoring did
not result in significant differences between the two
groups.
Discussion
To the best of our knowledge, this is the first report of
risk factors and clinical phenotypes associated with the
Beijing genotype in China. Many of the investigations
performed in other countries are limited by sample size or
loss of detailed epidemiological information [12,13,24,25].
Using data for 3634 strains identified in the first national
drug-resistance surveillance of China, our data describe
the detailed population structure of both Beijing and non-
Beijing genotype strains.
According to our study, the Beijing genotype is the
most predominant genotype in China, and several fac-
tors have an influence on its distribution among the
Table 2 Multivariate analysis of demographic
characteristics of tuberculosis patients according to
Mycobacterium tuberculosis genotype
Characteristic Adjusted ORs (95% CI) P value
Age group <25 years 1.35(1.03-1.78) 0.031
Hui Ethnicity 1.90 (1.06-3.41) 0.032
Uyghur Ethnicity 0.48(0.32-0.72) <0.001
Zhuang Ethnicity 0.34(0.21-0.54) <0.001
Urban People 1.08(0.91-1.28) 0.389
OR, odds ratio; CI, confidence interval.
Table 3 Clinical characteristics of tuberculosis patients according to Mycobacterium tuberculosis genotype
Characteristic Beijing genotype Other genotypes Odds ratios P
value(2290) (1344) (95% CI)
N (%) N (%)
Medical history
New case 1748(76.3%) 1071(79.7%) 1.00 -
Retreatment case 542(23.7%) 273(20.3%) 1.22(1.03-1.43) 0.021
History of tuberculosis contact
Yes 1864(81.4%) 1081(80.4%) 1.00 -
No 426(18.6%) 263(19.6%) 0.94(0.79-1.11) 0.483
Live in area with DOTS implemented
Before 2000 1276(55.7%) 793(59.0%) 1.00 -
2000 or after 1014(44.3%) 551(41.0%) 1.14(1.00-1.31) 0.056
Cough
No 122(5.3%) 66(4.9%) 1.00 -
<3 weeks 382(16.7%) 214(15.9%) 0.97(0.69-1.36) 0.862
≥3 weeks 1786(78.0%) 1064(79.2%) 0.91(0.67-1.24) 0.586
Hemoptysis
No 1715(74.9%) 949(70.6%) 1.00 -
Yes 575(25.1%) 395(29.4%) 0.81(0.69-0.94) 0.005
Fever
No 1167(51.0%) 758(56.4%) 1.00 -
Yes 1123(49.0%) 586(43.6%) 1.25(1.09-1.43) 0.002
Chest pain
No 1549(67.6%) 837(62.3%) 1.00 -
Yes 741(32.4%) 507(37.7%) 0.79(0.69-0.91) 0.001
OR, odds ratio; CI, confidence interval.
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population. Of all the factors, the correlation between
Beijing genotype with MDR and fluoroquinolone resist-
ance might influence the overall risk factors for Beijing
spoligotypes compared to other genotypes [21]. In
addition, a previous study in Vietnam indicated that the
Beijing genotype is associated with young patients (aged
less than 25 years), while research performed in other
countries has suggested that infection with the Beijing
genotype showed no association with a patient’s age
[13]. Consistent with results from Vietnam, we found
that young age (less than 25 years) showed a strong as-
sociation with infection by the Beijing genotype, suggest-
ing that the Beijing genotype will tend to become
dominant in the population in China, possibly because
young people tend to engage in greater levels of social
interaction. van Soolingen et al. hypothesized that BCG
vaccination may be one of the selective forces implicated
in the successful spread of the Beijing genotype [26].
This hypothesis is supported by results from other stud-
ies [27]. There is speculation that the Beijing genotype
strains may have diverged from a common ancestor in
the recent past. Although the exact date of their diver-
gence cannot be calculated, it is thought that this evolu-
tionary process has been completed in less than a
century [26]. Hence, one possible explanation for the
low spread of the Beijing genotype in the older popula-
tion is that older patients previously infected with the
non-Beijing genotype are resistant to the recently-
emerged Beijing genotype strain. Additionally, another
possible explanation could be an increased ongoing
transmission in the society of this form of TB, which
would be reflected in a higher prevalence in the young.
Further study is required to confirm the hypothesis.
In addition to age, infection with the Beijing genotype
was associated with ethnicity. Compared with Han,
people of both Uyghur and Zhuang ethnicities showed a
lower than average risk of infection with the Beijing
genotype. In a previous study we showed that the per-
centage of Uyghur patients infected with CAS1-DEHLI
genotype strains was significantly higher than that of
other ethnicities [21], and suggested that this may be
due to the frequent exchange between Uyghur people
and ethnicities from several neighboring Central Asian
countries where the CAS1-DEHLI genotype is highly
prevalent, since they share similar cultural traditions.
Since the Zhuang ethnicity is mainly distributed in
Guangxi Province in South China, the relatively low in-
cidence of the Beijing genotype is consistent with the
relatively low percentage of Beijing genotype strains in
Southern China [21]. In contrast to other ethnic minor-
ities, Hui ethnicity is defined rather based on cultural or
religious reasons instead of genetic one. Hence, the spe-
cial traditions and ways of living in Hui ethnicity may be
responsible for the high percentage of Beijing genotype.
However, a larger study is needed to answer additional
questions about the distribution of Beijing genotype and
non-Beijing genotype strains among different ethnicities.
With respect to occupation, we found strong associa-
tions between urban people and infection with Beijing
genotype strains. In China, rural people are usually living
in rural area with less density of population, who depend
on argricultural activities for their livelihoods, and there-
fore their mainly work condition is outside the building;
whereas urban people tend to live in urban areas with
more density of population and always work inside the
crowd public environment, which contribute to Beijing
infection of urban people. In addition, many studies have
suggested that the Beijing genotype is associated with re-
sistance to anti-tuberculosis drugs [18,28-30]. Due to the
unbalanced distribution of health care resources in
China [31], misuse and overuse of antibiotics is more
common in urban areas than in rural areas in China,
and this may account for the higher prevalence of drug-
resistant Beijing genotype strains among urban people.
In addition to demographic characteristics, patients
infected with Beijing genotype strains presented different
clinical profiles compared with those infected with non-
Beijing genotype strains. Both hemoptysis and chest pain
are common manifestations of pulmonary tuberculosis
[32]; moreover, massive hemoptysis is a life-threatening
condition with a poor treatment outcome in active tu-
berculosis patients [33]. In this study, we observed that
25.1% and 32.4% of patients infected with Beijing strains
had hemoptysis and chest pain, respectively, compared
with 29.4% and 37.7%, respectively, of those infected
with non-Beijing strains. These differences were statisti-
cally significant. That both symptoms have a lower oc-
currence in patients infected with the Beijing strain is
reasonable as the two symptoms often occur together in
the same patient. Our data indicate that chest symptoms
occur more frequently in patients infected with non-
Beijing strains. Our results are in agreement with a study
performed in Singapore which demonstrated that there
is a significantly higher frequency of cavitary disease in
patients infected with non-Beijing genotype strains [25].
Nevertheless, in studies on the CXR presentation of
patients completed in Indonesia and in the Netherlands
[12,20], the authors did not find any significant differ-
ence between the two groups. While more attention has
been given to the Beijing genotype than to other geno-
types due to the association of its supposed higher viru-
lence with relapse and treatment failure in humans
[13,20,34-36], our findings suggest that patients infected
with non-Beijing genotype strains may have more ser-
ious chest phenotypes.
Fever is a typical clinical symptom of tuberculosis
patients, and recent findings have revealed that the fre-
quency with which fever is observed is more frequently
Pang et al. BMC Infectious Diseases 2012, 12:354 Page 5 of 7
http://www.biomedcentral.com/1471-2334/12/354
reported in non-Beijing genotype infected patients than
in patients infected with the Beijing genotype [25]. In
contrast, we found that fevers occurred in a significantly
higher proportion of patients infected with Beijing geno-
type strains in China than in those infected with non-
Beijing genotype strains. Our results are in agreement
with a cohort study by Parwati et al. which showed that
more patients infected with Beijing genotype strains
developed fever during treatment [20].
Conclusion
In summary, we have shown that ethnicity, occupation
and earlier treated patients are risk factors for infection
with Beijing genotype strains, and identified clinical phe-
notypes that are strongly associated with the genotype of
the strain with which a patient is infected. Our data sug-
gest that urban people, Hui ethnicity and earlier treated
patients are all high risk factors, while older age group,
and Uyghur or Zhuang ethnicity show a lower than aver-
age risk for infection with the Beijing genotype. Other
characteristics, including sex, economic situation, con-
tact history and implementation of DOTS monitoring
did not vary between patients infected with Beijing and
non-Beijing genotype strains. In addition, the high pro-
portion of hemoptysis and chest pain appearing in non-
Beijing genotype infected patients indicates that more at-
tention should be given to basic research on non-Beijing
genotype strains.
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